Intrapleural Catheter Daily Versus Three Times a Week Drainage

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00761618

Recruitment Status : Active, not recruiting

First Posted : September 29, 2008

Last Update Posted : June 30, 2022

Sponsor:

Collaborator:

CareFusion

Information provided by (Responsible Party):

M.D. Anderson Cancer Center

Study Description

Brief Summary:

The goal of this clinical research study is to learn if draining the IPC every day is better at than draining it 3 times a week.

Condition or disease	Intervention/treatment	Phase
Advanced Cancer Pleural Effusion	Procedure: Intrapleural catheter (IPC) drained Procedure: IPC Placement Radiation: Chest X-Ray	Phase 2

Show detailed description

Detailed Description:

An IPC is a silicone (rubberlike) tube that is inserted into the chest cavity to drain excess fluid that is in your chest. At MD Anderson, patients are told to drain their IPC every day. At other institutions, patients are told to drain their IPC less often.

Before IPC Placement:

Before you can have the IPC inserted, the following tests and procedures will be performed to help the doctor decide if you need to have an IPC inserted:

You will perform a 6 minute walk test to learn your check your breathing ability and fatigue level. To perform the walk test, you will be asked to walk as far as possible around cones on a flat indoor course that is about 40 yards long. You will walk at your own pace and can take breaks at any time if necessary.
After signing this consent, you will fill out 2 questionnaires asking questions about how you feel and any symptoms you may have. These questionnaires will take about 20-30 minutes to complete.

IPC placement:

You will have an IPC placed to drain the fluid in your chest cavity. You will be given a separate consent for to sign for this procedure and your doctor will give you detailed instructions regarding the procedure itself.

Study Groups:

A chest x-ray will be performed right after the IPC placement. You will be randomly assigned (as in the flip of a coin) to 1 of 2 groups, after your chest x-ray or the following day when you return to clinic for follow up. Group 1 will have their IPC drained every day, and Group 2 will have their IPC drained 3 times a week (Monday, Wednesday, and Friday or Tuesday, Thursday, and Saturday). You will be given detailed instructions on when and how to drain your catheter.

Follow-Up Visits:

Two (2) weeks after you receive the IPC, you will return to the clinic for a follow-up visit so the doctor can check your IPC for possible leaking, infection, and see how much pleural fluid has drained. After the follow-up visit at 2 weeks, you will come into the clinic every 4 weeks until your IPC is removed. During each follow-up visit the following tests and procedures will be performed to see how your condition has changed:

You will have a chest x-ray to see if the amount of pleural fluid has decreased and to see if your lung has re-expanded.
You will perform the 6 minute walk test.
You will complete the same 2 questionnaires.
The IPC will be drained.

After the IPC is removed, at 3 and 6 months, you will have follow-up visits at M. D. Anderson or at your local doctor's office. At these visits you will have chest x-rays to see if the pleural fluid has come back or not.

The study personnel will contact you by phone, email or mail periodically during the study and at 3 months and 6 months after the IPC has been removed to check on your status. The phone calls, email, or mail follow-up will take about 5-10 minutes to complete. You will be asked how you are doing and if you have any questions or concerns that you may want to discuss with the your doctor. You will also be asked if you have had a chest x-ray since being off study. If you have had an x-ray, you will be asked to share the results with the study doctor.

This is an investigational study.

Up to 250 patients will take part in this study. All will be enrolled at MD Anderson.

Study Design

Layout table for study information

Study Type :	Interventional (Clinical Trial)
Actual Enrollment :	257 participants
Allocation:	Randomized
Intervention Model:	Single Group Assignment
Masking:	None (Open Label)
Primary Purpose:	Treatment
Official Title:	Effectiveness of Daily Versus Three Times a Week Drainage After Placement of Intrapleural Catheters for the Palliative Management of Pleural Effusions Associated With Malignancies
Actual Study Start Date :	August 22, 2008
Estimated Primary Completion Date :	August 31, 2024
Estimated Study Completion Date :	August 31, 2024

Arms and Interventions

Arm	Intervention/treatment
Experimental: Arm 1 - Daily Intrapleural Catheters (IPC) drained every day	Procedure: Intrapleural catheter (IPC) drained IPC drained daily (Group 1) or 3 times per week (Group 2) Procedure: IPC Placement IPC placed in chest cavity to drain excess fluid Other Name: Indwelling Pleural Catheter Radiation: Chest X-Ray Chest X-Rays at 3 and 6 month follow up visits
Experimental: Arm 2 - 3 Times a Week IPC drained 3 times a week	Procedure: Intrapleural catheter (IPC) drained IPC drained daily (Group 1) or 3 times per week (Group 2) Procedure: IPC Placement IPC placed in chest cavity to drain excess fluid Other Name: Indwelling Pleural Catheter Radiation: Chest X-Ray Chest X-Rays at 3 and 6 month follow up visits

Outcome Measures

Primary Outcome Measures :

Time to Pleurodesis (TTP) [ Time Frame: 2 weeks after intrapleural catheter placement ]
Time to pleurodesis (TTP), defined as the time from catheter insertion to catheter removal.

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information

Ages Eligible for Study:	18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patients with symptomatic pleural effusion requiring placement of an IPC.
Signed informed consent prior to any study related procedures.
Subject must be age 18 years or over.

Exclusion Criteria:

Any of the following interventions on the affected hemithorax: prior IPC, prior chest tube placement, history of chemical or mechanical pleurodesis, history of thoracotomy within 4 weeks incompletely healed surgical incision before randomization.
Evidence of empyema or history of empyema of the affected hemithorax
Non-correctable bleeding diathesis
Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule.
Evidence of severe or uncontrolled systemic disease or any concurrent condition which in the Principal Investigator's opinion makes it undesirable for the patient to participate in the trial or which would jeopardize compliance with the protocol.
Participation in any clinical trial that prevents randomization of the subject to either strategy.
Clinical evidence of skin infection at the potential site of IPC placement.
Current or prior IPC placement, or any intervention to manage recurrent malignant pleural effusion on the contralateral hemithorax (excluding thoracentesis).

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00761618

Locations

Layout table for location information

United States, Texas
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030

Sponsors and Collaborators

M.D. Anderson Cancer Center

CareFusion

Investigators

Layout table for investigator information

Principal Investigator:	Carlos A. Jimenez, MD	M.D. Anderson Cancer Center

More Information

Additional Information:

MD Anderson Cancer Center This link exits the ClinicalTrials.gov site

Layout table for additonal information

Responsible Party:	M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:	NCT00761618
Other Study ID Numbers:	2007-0808 NCI-2012-01673 ( Registry Identifier: NCI CTRP-Clinical Trials Reporting Registry )
First Posted:	September 29, 2008 Key Record Dates
Last Update Posted:	June 30, 2022
Last Verified:	June 2022

Layout table for additional information

Studies a U.S. FDA-regulated Drug Product:	No
Studies a U.S. FDA-regulated Device Product:	No

Keywords provided by M.D. Anderson Cancer Center:


Intrapleural catheter IPC Pleurodesis PD Pleural effusion	Fluid in the chest cavity Recurrent malignant pleural effusion MPE Pleural inflammatory response

Additional relevant MeSH terms:

Layout table for MeSH terms

Pleural Effusion Pleural Diseases Respiratory Tract Diseases

To Top